MobilEye Global Inc vs Tilray Brands Inc — how do they compare? MobilEye Global Inc trades at $7.12 (market cap $6.00B), while Tilray Brands Inc trades at $3.5 (market cap $530.54M). The key difference: MobilEye Global Inc is far larger — about 11.3× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 7,007,849). Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Tilray Brands Inc for 31 Days on average.
| MBLY | TLRY | |
|---|---|---|
Market Cap | $6.00B | $530.54M |
Volume | 7,007,849 | 9,099,075 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.42 | $21.00 |
52-Week Low | $6.56 | $3.57 |
Typical Hold Time | 15 Days | 31 Days |
Enterprise Value | $4.56B | $684.46M |
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.14, down 0.14% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $2.0B in 2026 but faces significant profitability challenges with a -201.49% net income margin. Analyst consensus is mixed with 57.7% buy ratings but a bearish technical outlook from indicators.
The stock presents a high-risk opportunity with substantial upside to the $10.83 consensus target but requires careful monitoring of profitability improvements. Key risks include persistent losses, competitive pressures in autonomous driving, and execution challenges in robotaxi expansion.
TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.
TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →